The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 214 participants.

Also called NCT07143019

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 214 participants (planned count) (from the registry)
Sponsor
  • Phenox GmbH Registry lists this organization as a collaborator
Registry
  • NCT NCT07143019
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07143019. Allocation not applicable; no masking; primary purpose treatment. Start 2026-03-16 (actual); primary completion 2027-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms
Acronym
PIANO
Condition
Hemorrhagic Stroke
Condition
Aneurysm, Intracranial
Condition
Saccular Aneurysm
Condition
Fusiform Aneurysm
Condition
Brain Aneurysm
Intervention (Device)
Flow diversion
Lead sponsor
phenox Inc. (class: industry)
Collaborator
Phenox GmbH (class: industry)

Record details

Record id
cardio:ct-nct07143019
Content hash
244ebe39a970791be31dab305230e388ace22859348b12f7ee2007686d5e1b73